-
This session examines type 2 diabetes as a major co-morbidity in people with COPD, focusing on the bidirectional impact each condition has on morbidity, mortality, and quality of life. We’ll explore shared risk factors, the role of systemic inflammation, and how COPD treatments—particularly corticosteroids—affect glycaemic control. The session will provide practical, primary-care-focused guidance on conducting […]
book Now
Free